Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_3213_Библиотеки_им_академика_М_И_Перельмана
.pdf
Источник KingMed.info
371
Pantelis A.S., Panagiotis C.S., Panagiotis I.G. et al. Effect of thiazolidinediones on albuminuria and
proteinuria in diabetes: ameta-analysis // Am. J. Kidney Dis. 2010.
Vol. 55, N. 5. P. 835-847.
Papatheodoridis G.V., Chrysanthos N., Savvas S. et al. Diabetes mellitus in chronic hepatitis B and C:
prevalence and potential association with the extent of liver fibrosis //
J. Viral Hepat. 2006. Vol. 13, N. 5. P. 303-310.
Pararajasingam G., Hofsten D.E., Logstrup B.B. et al. Newly detected abnormal glucose regulation and
long-term prognosis after acute myocardial infarction // Int. J.
Cardiol. 2016. Vol. 214. P. 310-315.
Parikh T., Goyal D., Scarff J.R., Lippmann S. Antipsychotic drugs and safety concerns for breast-feeding
infants // South. Med. J. 2014. Vol. 107, N. 11. P. 686-688.
Park M., Vittinghoff E., Shlipak M.G. et al. Associations of N-terminal pro-B-type natriuretic peptide with
kidney function decline in persons without clinical heart failure in the Heart and Soul Study // Am.
Heart J. 2014. Vol. 168. P. 931-939.e2.
Park S.H., Kim W., Park C.S. et al. A comparison of clopidogrel responsiveness in patients with versus
without chronic renal failure // Am. J. Cardiol. 2009. Vol. 104,
N. 9. P. 1292-1295.
Park Y., Bateman B.T., Kim D.H. et al. Use of haloperidol versus atypical antipsychotics and risk of in-
hospital death in patients with acute myocardial infarction: cohort
study // BMJ. 2018. Vol. 360. P. 655-662.
Park Y., Hernandez-Diaz S., Bateman B. et al. Continuation of atypical antipsy-chotic medication during
early pregnancy and the risk of gestational diabetes // Am. J. Psyichiatry. 2018. Vol. 175, N. 6. P. 564-
574. doi: 10.1176/appi.ajp.2018.17040393.
Parodi G. Morphine May Delay Onset of New Antiplatelets in Primary PCI.
EuroPCR, 2014.
Passarelli M.C., Jacob-Filho W., Figueras A. Adverse drug reactions in an elderly hospitalised population:
inappropriate prescription is a leading cause // Drugs Aging.
2005. Vol. 22, N. 9. P. 767-777.
Pasternak B., Svanström H., Molgaard-Nielsen D. et al. Metoclopramide in pregnancy and risk of major
congenital malformations and fetal death // JAMA. 2013.
Vol. 310, N. 15. P. 1601-1611.
Pathak R.D., Schroeder E.B., Seaquist E.R. et al. Severe hypoglycemia requiring medical intervention in a
large cohort of adults with diabetes receiving care in U.S. Integrated health care delivery systems:
2005-2011 // Diabetes Care. 2016. Vol. 39,
N. 3. P. 363-370.
Patorno E., Huybrechts K.F., Bateman B.T. et al. Lithium use in pregnancy and the risk of cardiac
malformations // N. Engl. J. Med. 2017. Vol. 376, N. 23. P. 2245-2254.
Источник KingMed.info
372
Pawar A., Desai R.J., Solomon D.H. et al. Risk of serious infections in tocilizumab versus other biologic
drugs in patients with rheumatoid arthritis: a multidatabase cohort study // Ann. Rheumatic Dis. 2019.
Vol. 78. P. 456-464.
Paykel E.S., Fleminger R., Watson J.P. Psychiatric side effects of antihypertensive drugs other than
reserpine // J. Clin. Psychopharmacol. 1982. Vol. 2, N. 1. P. 14-39.
Peacock W.F., Tamayo S., Sicignano N. et al. Comparison of the incidence of major bleeding with
rivaroxaban use among nonvalvular atrial fibrillation patients with versus
without diabetes mellitus // Am. J. Cardiol. 2017. Vol. 119, N. 5. P. 753-759.
Pedersen L.H., Henriksen T.B., Vestergaard M. et al. Selective serotonin reuptake inhibitors in pregnancy
and congenital malformations: p opulation based cohort study // BMJ. 2009. Vol. 339. Article ID b3569.
Pennlert J., Overholser R., Asplund K. et al. Optimal timing of anticoagulant treatment after
intracerebral hemorrhage in patients with atrial fibrillation // Stroke. 2017.
Vol. 2. P. 314-320.
Pepa P., Lee K., Huynh H. et al. Safety of Risperidone for Acute Agitation and Alcohol Intoxication in
Emergency Department Patients // J. Emergency Med. 2017.
Vol. 4. P. 530-535.
Pergialiotis V., Frountzas M., Prodromidou A. et al. Propranolol and oxytocin versus oxytocin alone for
induction and augmentation of labor: a meta-analysis of randomized trials // Arch. Gynecol. Obstet.
2016. Vol. 293, N. 4. P. 721-729.
Peri-Okonny P., Patel K., Jones P. et al. Low diastolic blood pressure is associated with angina in
patients with chronic coronary artery disease // J. Am. Coll. Cardiol.
2018. Vol. 11. P. 1227-1232.
Perkins R.M., Tang X., Bengier A.C. et al. Variability in estimated glomerular filtration rate is an
independent risk factor for death among patients with stage 3 chronic
kidney disease // Kidney Int. 2012. Vol. 82, N. 12. P. 1332-1338.
Petrykiv S., Sjöström C.D., Greasley P.J., Xu J. et al. Differential effects of dapa-gliflozin on cardiovascular
risk factors at varying degrees of renal function // Clin. J.
Am. Soc. Nephrol. 2017. Vol. 12, N. 5. P. 751-759.
Pezzilli R., Morselli-Labate A.M., Corinaldesi R. NSAIDs and acute pancreatitis: asystematic review //
Pharmaceuticals. 2010. Vol. 3, N. 3. P. 558-571.
Phan B.A., Munoz L., Shadzi P. et al. Effects of niacin on glucose levels, coronary stenosis progression,
and clinical events in subjects with normal baseline glucose levels (<100 mg/dl) // Am. J. Cardiol. 2013.
Vol. 111, N. 3. P. 352-355.
Phan K., Moore J.M., Griessenauer C.J. et al. Aspirin and risk of subarachnoid hemorrhage // Stroke.
2017. Vol. 5. P. 1210-1217.
Pignatelli P., Pastori D., Vicario T. et al. Relationship between Mediterranean diet and time in
therapeutic range in atrial fibrillation patients taking vitamin K antagonists // Europace. 2015. Vol. 17. P.
1223-1228.
Источник KingMed.info
373
Pinkerton J.V., Archer D.F., Guico-Pabia C.J. et al. Maintenance of the efficacy of desvenlafaxine in
menopausal vasomotor symptoms: a 1-year randomized controlled
trial // Menopause. 2013. Vol. 20, N. 1. P. 38-46.
Poh J., Knowles S. Safety of 5-aminosalicylic acid derivatives in patients with sensitivity to acetylsalicylic
acid and nonsteroidal anti-inflammatory drugs // Can. J.
Hosp. Pharm. 2014. Vol. 67, N. 1. P. 35-38.
Posch F., Ay C., Stöger H. et al. Longitudinal kidney function trajectories predict major bleeding,
hospitalization and death in patients with atrial fibrillation and chronic kidney disease // Intern. J.
Cardiology. 2019. Vol. 282. P. 47-52.
Polcwiartek C., Kragholm K., Schjerning O. et al. Cardiovascular safety of antipsychotics: a clinical
overview // Expert. Opin. Drug. Saf. 2016. Vol. 15, N. 5. P. 679-688.
Pothineni N.V., Rochlani Y., Vallurupalli S. et al. Comparison of angiographic burden of coronary artery
disease in patients with versus without hepatitis C infection //
Am. J. Cardiol. 2015. Vol. 116. P. 1041-1044.
Pothineni N.V.K.C., Delongchamp R., Vallurupalli S. et al. Impact of hepatitis C seropositivity on the risk
of coronary heart disease events // Am. J. Cardiol. 2014.
Vol. 114. P. 1841-1845.
Pothineni N.V., Kancharla K., Katoor A.J. et al. Coronary artery injury related to catheter ablation of
cardiac arrhythmias: A systematic review // J. Cardiovasc.
Electrophysiol. 2019. Vol. 30, N. 1. P. 92-101.
Preiss D., Campbell R.T., Murray H.M. et al. The effect of statin therapy on heart failure events: a
collaborative meta-analysis of unpublished data from major randomized trials // Eur. Heart J. 2015. Vol.
36. P. 1536-1546.
Preiss D., Seshasai S.R.K., Welsh P. et al. Risk of incident diabetes with intensive-dose compared with
moderate-dose statin therapy // JAMA. 2011. Vol. 305, N. 24.
P. 2556-2564.
Psaila M., Fsadni P., Montefort S. Chronic cough as a complication of treatment
with statins: a case report // Ther. Adv. Respir. Dis. 2012. Vol. 6, N. 4. P. 243-246.
Qirjazi E., McArthur E., Nash D.M. et al. Risk of Ventricular Arrhythmia with Citalopram and
Escitalopram: A Population-Based Study // PLoS One. 2016.
Vol. 11, N. 2. e0160768.
Qureshi W., Mittal C., Patsias I. et al. Restarting anticoagulation and outcomes after major
gastrointestinal bleeding in atrial fibrillation // Am. J. Cardiol. 2014. Vol. 113,
N. 4. P. 662-668.
Radley D.C., Finkelstein S.N., Stafford R.S. Off-label prescribing among office-
based physicians // Arch. Intern. Med. 2006. Vol. 166, N. 9. P. 1021-1026.
Источник KingMed.info
374
Rahimi K., Mohseni H., Kiran A. et al. Elevated blood pressure and risk of aortic valve disease: a cohort
analysis of 5.4 million UK adults // Eur. Heart J. 2018. Vol. 39.
P. 3596-3603.
Rai S.K., Fung T.T., Lu N. et al. The Dietary Approaches to Stop Hypertension (DASH) diet, Western diet,
and risk of gout in men: prospective cohort study // BMJ.
2017. Vol. 357. Article ID j1794.
Rainer T.H., Cheng C.H., Janssens H.J. et al. Oral prednisolone in the treatment of acute gout:
apragmatic, multicenter, double-blind, randomized trial // Ann. Intern. Med. 2016. Vol. 164. P. 464-471.
Rajan J.P., Wineinger N.E., Stevenson D.D. et al. Prevalence of aspirin-exacerbated respiratory disease
among asthmatic patients: a meta-analysis of the literature // J. Allergy Clin. Immunol. 2015. Vol. 135,
N. 3. P. 676-681.
Rakoski M.O., Singal A.G., Rogers M.A., Conjeevaram H. Meta-analysis: insulin sensitizers for the
treatment of non-alcoholic steatohepatitis // Aliment. Pharmacol. Ther. 2010. Vol. 32, N. 10. P. 1211-
1221.
Rana J.S., Liu J.Y., Moffet H.H. et al. Metabolic dyslipidemia and risk of coronary heart disease in 28,318
adults with diabetes mellitus and low-density lipoprotein cholesterol <100 mg/dl // Am. J. Cardiol.
2015. Vol. 116, N. 11. P. 1700-1704.
Ranjbar S., Pai N.B., Deng C. The Association of antidepressant medication and body weight gain //
Online J. Health Allied Sci. 2013. Vol. 12, N. 1. P. 1-9.
Rastogi S., Rodriguez J.J., Kapur V., Schwarz E.R. Why do patients with heart failure suffer from erectile
dysfunction? A critical review and suggestions on how to approach this problem // Int. J. Impot. Res.
2005. Vol. 17, suppl. 1. P. S25-S36.
Ravi V.D., Mustafa I.A., Gregg C.F. et al. Effect of serum insulin on the association between
hyperuricemia and incident heart failure // Am. J. Cardiol. 2010. Vol. 106,
N. 8. P. 1134-1138.
Ravichandran J., Woon S., Quek Y. et al. High-Sensitivity Cardiac Troponin I Levels in Normal and
Hypertensive Pregnancy // Am. J. Med. 2019. Vol. 3. P. 362-366.
Ravindran P.P., Zang W., Renukunta S. et al. Effect of comedication of bupropion and other
antidepressants on body mass index // Ther. Adv. Psychopharmacol. 2015.
Vol. 5, N. 3. P. 158-165.
Ray W.A., Chung C.P., Murray K.T. et al. Atypical antipsychotic drugs and the risk of sudden cardiac
death // N. Engl. J. Med. 2009. Vol. 360, N. 3. P. 225-235.
Razvi S., Shakoor A., Vanderpump M., Weaver J.U. et al. The influence of age on the relationship
between subclinical hypothyroidism and ischemic heart disease
a metaanalysis // J. Clin. Endocrinol. Metab. 2008. Vol. 93, N. 8. P. 2998-3007.
Razvi S., Weaver J.U., Butler T.J., Pearce S.S. Levothyroxine treatment of subclinical hypothyroidism, fatal
and nonfatal cardiovascular events, and mortality levothyroxi-
ne treatment // Arch. Intern. Med. 2012. Vol. 172, N. 10. P. 811-817.
Источник KingMed.info
375
Reddy Y.V., Melenovsky V., Redfield M.M.et al. High-output heart failure:
a 15-year experience // J. Am. Coll. Cardiol. 2016. Vol. 68, N. 5. P. 473-482.
Reed R.M., Eberlein M., Girgis R.E. et al. Coronary artery disease is under-diagnosed and under-treated
in advanced lung disease // Am. J. Med. 2012. Vol. 125,
N. 12. P. 1228. e13-e22.
Reiberger T., Ulbrich G., Ferlitsch A. et al. Carvedilol for primary prophylaxis of variceal bleeding in
cirrhotic patients with haemodynamic non-response to proprano-lol // Gut. 2013. Vol. 62, N. 11. P.
1634-1641.
Renda G., Ricci F., Giugliano R.P., De Caterina R. Non-vitamin K antagonist oral anticoagulants in
patients with atrial fibrillation and valvular heart disease // J. Am.
Coll. Cardiol. 2017. Vol. 69, N. 11. P. 1363-1371.
Renet S., Chaumais M.-C., Antonini T. et al. Extreme bradycardia after first doses of sofosbuvir and
daclatasvir in patients receiving amiodarone: 2 cases including a
rechallenge // Gastroenterology. 2015. Vol. 149. P. 1378-1380. 1.
Reno C.M., Daphna-Iken D., Chen Y.S. et al. Severe hypoglycemia-induced lethal cardiac arrhythmias
are mediated by sympathoadrenal activation // Diabetes. 2013. Vol. 62, N. 10. P. 3570-3581.
Rienstra M., Damman K., Mulder B.A. et al. Beta-blockers and outcome in heart failure and atrial
fibrillatioN. A meta-analysis // JACC Heart Fail. 2013. Vol. 1.
P. 21-28.
Rigotti N.A., Pipe A.L., Benowitz N.L. et al. Efficacy and safety of varenicline for smoking cessation in
patients with CVD // Circulation. 2010. Vol. 121. P. 221-229. Riihimäki M., Thomsen H., Sundquist K.,
Hemminki K. Colorectal cancer patients.
What do they die of? // Frontline Gastroenterol. 2012. Vol. 3, N. 3. P. 143-149.
Ritsinger V., Malmberg K., Martensson A. et al. Intensified insulin-based gly-caemic control after
myocardial infarction: mortality during 20 year follow-up of the randomised DIGAMI 1 trial // Lancet.
Diabetes Endocrinol. 2014. Vol. 2, N. 8. P. 627-633.
Robinson B.M., Tong L., Zhang J. et al. Blood pressure levels and mortality risk among hemodialysis
patients in the Dialysis Outcomes and Practice Patterns Study //
Kidney Int. 2012. Vol. 82, N. 5. P. 570-580.
Rodondi N., den Elzen W.P.J., Bauer D.C. et al. Subclinical hypothyroidism and the risk of coronary heart
disease and mortality // JAMA. 2010. Vol. 304, N. 12.
P. 1365-1374.
Roffi M., Chew D.P., Mukherjee D. et al. Platelet glycoprotein IIb/IIIa inhibitors reduce mortality in
diabetic patients with non-ST-segment-elevation acute coronary
syndromes // Circulation. 2001. Vol. 104. P. 2767-2771.
Rohrer C.K., Page R.L., Shakar S.F., Lindenfeld J. Carvedilol for the treatment of benign prostatic
hypertrophy in patients with heart failure? // J. Card. Fail. 2011.
Источник KingMed.info
376
Vol. 17, N. 10. P. 875-877.
Romley J.A., Gong C., Jena A.B. et al. Association between use of warfarin with common sulfonylureas
and serious hypoglycemic events: retrospective cohort analysis // BMJ. 2015. Vol. 351. Article ID h6223.
Roumie C.L., Hung A.M., Greevy R.A. et al. Comparative effectiveness of sulfonyl-urea and metformin
monotherapy on cardiovascular events in type 2 diabetes mellitus. A cohort study // Ann. Intern. Med.
2012. Vol. 157, N. 9. P. 601-610.
Rubin J., Matsushita K., Ballantyne C.M. et al. Chronic hyperglycemia and sub-clinical myocardial injury
// J. Am. Coll. Cardiol. 2012. Vol. 59, N. 5. P. 484-489.
Ruiz-Laiglesia F.J., Sanchez-Marteles M., Perez-Calvo J.I. et al. Comorbidity in
heart failure / Results of the Spanish RICA Registry // QJM. 2014. Vol. 107, N. 12. P. 989-994.
Rumack B., Heard K., Green J. et al. Effect of therapeutic doses of acetaminophen (up to 4 g/day) on
serum alanine aminotransferase levels in subjects consuming etha-nol // Pharmacotherapy. 2012. Vol.
32, N. 9. P. 784-791.
Rushton C.A., Kadam U.T. Impact of non-cardiovascular disease comorbidity on cardiovascular disease
symptom severity: a population-based study // Int. J. Cardiol.
2014. Vol. 175, N. 1. P. 154-161.
Russo J.J., Goodman S.G., Cantor W.J. et al. Does renal function affect the efficacy or safety of a
pharmacoinvasive strategy in patients with ST-elevation myocardial infarction? A meta-analysis // Am.
Heart J. 2017. Vol. 193. P. 46-54.
Russo A., Autelitano M., Bisanti L. Spironolactone and gastrointestinal bleeding: a population based
study // Pharmacoepid. Drug. Saf. 2008. Vol. 17, N. 5. P. 495-500.
Sadr-Azodi O., Mattsson F., Bexlius T. et al. Association of oral glucocorticoid use with an increased risk
of acute pancreatitis: apopulation-based nested case-control study // JAMA Intern. Med. 2013. Vol.
173, N. 6. P. 444-449.
Salata K., Syed M., Hussain M.A. et al. Renin-angiotensin system blockade does not attenuate
abdominal aortic aneurysm growth, rupture rate, or perioperative mortality after elective repair // J.
Vasc. Surg. 2018. Vol. 67, N. 2. P. 629-636.e2.
Salliot C., Dougados M., Gossec L. Risk of serious infections during rituximab, abatacept and anakinra
treatments for rheumatoid arthritis: meta-analyses of randomised placebo-controlled trials // Ann.
Rheum. Dis. 2009. Vol. 68, N. 1. P. 25-32.
Salpeter S., Ormiston T., Salpeter E., Wood-Baker R. Cardioselective beta-blockers for reversible airway
disease // Cochrane Database Syst. Rev. 2011. Vol. 11.
Salpeter S.R., Buckley N.S., Ormiston T.M. et al. Meta-analysis: effect of long-acting {beta}-agonists on
severe asthma exacerbations and asthma-related deaths //
Ann. Intern. Med. 2006. Vol. 144. P. 904-912.
Salvo F., Pariente A., Shakir S. et al. Sudden cardiac and sudden unexpected death related to
antipsychotics: a meta-analysis of observational studies // Clin. Pharmacol.
Ther. 2016. Vol. 99, N. 3. P. 306-314.
Sammaritano L.R., Bermas B.L. Rheumatoid arthritis medications and lactation //
Источник KingMed.info
377
Curr. Opin. Rheumatol. 2014. Vol. 26, N. 3. P. 354-360.
Sampat U., Varadarajan P., Turk R. et al. Effect of beta-blocker therapy on survival in patients with
severe aortic regurgitation: results from a cohort of 756 patients //
J. Am. Coll. Cardiol. 2009. Vol. 54, N. 5. P. 452-457.
Sansone R.A., Sansone L.A. Driving on antidepressants: cruising for a crash? //
Psychiatry (Edgmont). 2009. Vol. 6, N. 9. P. 13-16.
Sattar N., Preiss D., Murray N.M. et al. Statins and risk of incident diabetes: a collaborative meta-
analysis of randomised statin trials // Lancet. 2010. Vol. 375.
P. 735-742.
Sauvage M.F., Rousseau A., Marquet P. et al. In vitro and in vivo study of the antithyroid side effects of
trimeprazine// Toxicol. Appl. Pharmacol. 1999. Vol. 158, N. 2.
P. 125-131.
Schaer B.A., Schneider C., Jick S.S. et al. Risk for incident atrial fibrillation in patients who receive
antihypertensive drugs // Ann. Intern. Med. 2010. Vol. 152, N. 2.
P. 78-84.
Schafer I., von Leitner E.C., Schon G. et al. Multimorbidity patterns in the elderly: a new approach of
disease clustering identifies complex interrelations between chronic conditions // PLoS One. 2010. Vol.
5, N. 12. Article ID e15941.
Schelleman H., Bilker W.B., Brensinger C.M. et al. Fibrate/statin initiation in warfarin users and
gastrointestinal bleeding risk // Am. J. Med. 2010. Vol. 123, N. 2.
P. 151-157.
Schellevis F.G. Comorbidity of chronic disease in general practice // J. Clin.
Epidemiol. 1993. Vol. 46, N. 5. P. 469-473.
Schembri S., Williamson P.A., Short P.M. et al. Cardiovascular events after clari-thromycin use in lower
respiratory tract infections: analysis of two prospective cohort studies // BMJ. 2013. Vol. 346. Article ID
f1235.
Schepke M., Werner E., Biecker E. et al. Hemodynamic effects of the angiotensin II receptor antagonist
irbesartan in patients with cirrhosis and portal hypertension //
Gastroenterology. 2001. Vol. 121. P. 389-395.
Schillie S.F., Xing J., Murphy T.V., Hu D.J. Prevalence of hepatitis B virus infection among persons with
diagnosed diabetes mellitus in the United States, 1999-2010 // J. Viral Hepat. 2012. Vol. 19, N. 9. P.
674-676.
Schjerning O. A., Gislason G.H., McGettigan P. et al. Association of NSAID use with risk of bleeding and
cardiovascular events in patients receiving antithrombotic
therapy after myocardial infarction // JAMA. 2015. Vol. 313, N. 8. P. 805-814.
Schlienger R.G., Kraenzlin M.E., Jick S.S., Meier C.R. Use of beta-blockers and risk of fractures // JAMA.
2004. Vol. 292, N. 11. P. 1326-1332.
Источник KingMed.info
378
Schmeltzer P.A., Kosinski A.S., Kleiner D.E. et al. Liver injury from nonsteroi-dal anti-inflammatory drugs
in the United States // Liver Int. 2016. Vol. 36, N. 4.
P. 603-609.
Schmidt A.F., Swerdlow D.I., Holmes M. et al. PCSK9 genetic variants and risk of type 2 diabetes: a
mendelian randomisation study // Lancet Diabetes Endocrinol. 2017.
Vol. 5, N. 2. P. 97-105.
Schmidt L.B., Goertz S., Wohlfahrt J. et al. Recurrent intracerebral hemorrhage: associations with
comorbidities and medicine with antithrombotic effects // PLoS One. 2016. Vol. 11, N. 11. Article ID
e0166223.
Schmidt M., Christiansen C.F., Mehnert F. et al. Non-steroidal anti-inflammatory drug use and risk of
atrial fibrillation or flutter: population based case-control study //
BMJ. 2011. Vol. 343. Article ID d3450.
Schmidt P.J., Ben Dor R., Martinez P.E. et al. Effects of estradiol withdrawal on mood in women with
past perimenopausal depression: arandomized clinical trial // JAMA Psychiatry. 2015. Vol. 72, N. 7. P.
714-726.
Schmitt J., Duray G., Gersh B.J. et al. Atrial fibrillation in acute myocardial infarction: a systematic review
of the incidence, clinical features and prognostic implications // Eur. Heart J. 2009. Vol. 30, N. 9. P.
1038-1045.
Schneider M.P., Hua T.A., Bohm M. et al. Prevention of atrial fibrillation by renin-angiotensin system
inhibition: a meta-analysis // J. Am. Coll. Cardiol. 2010. Vol. 55,
N. 21. P. 2299-2307.
Schnell K., Weiss C.O., Lee T. et al. The prevalence of clinically-relevant comorbid conditions in patients
with physician-diagnosed COPD: a cross-sectional study using data from NHANES 1999-2008 // BMC
Pulm. Med. 2012. Vol. 12. P. 26.
Schofield P.M., Whorwell P.J., Brooks N.H. et al. Oesophageal function in patients with angina pectoris:
a comparison of patients with normal coronary angiograms and patients with coronary artery disease
// Digestion. 1989. Vol. 42, N. 2. P. 70-8.
Schramm T.K., Gislason G.H., Vaag A. et al. Mortality and cardiovascular risk associated with different
insulin secretagogues compared with metformin in type 2 diabetes, with or without a previous
myocardial infarction: a nationwide study // Eur.
Heart J. 2011. Vol. 32. P. 1900-1908.
Schwarz E.R., Rastogi S., Kapur V. et al. Erectile dysfunction in heart failure
patients // J. Am. Coll. Cardiol. 2006. Vol. 48. P. 1111-1119.
Scirica B.M., Cannon C.P., Emanuelsson H. et al. The incidence of bradyarrhyth-mias and clinical
bradyarrhythmicevents in patients with acute coronary syndromes treated with ticagrelor or
clopidogrel in the PLATO // J. Am. Coll. Cardiol. 2011.
Vol. 57, N. 19. P. 1908-1916.
Segawa K., Niwa Y., Arisawa T. et al. Incidence of peptic ulcer in men is inversely correlated with blood
pressure: study in an apparently healthy Japanese population //
Источник KingMed.info
379
Am. J. Gastroenterol. 1995. Vol. 90, N. 3. P. 399-402.
Seitz D.P., Campbell R.J., Bell C.M. et al. Short-term exposure to antidepres-sant drugs and risk of acute
angle-closure glaucoma among older adults // J. Clin.
Psychopharmacol. 2012. Vol. 32, N. 3. P. 403-407.
Self T.H., Wallace J.L., Sakaan S., Sands C.W. Effect of body weight on dose of
vitamin K antagonists // South. Med. J. 2015. Vol. 108, N. 10. P. 637-643.
Selmer C., Olesen J.B., Hansen M.L. et al. The spectrum of thyroid disease and risk of new onset atrial
fibrillation: a large population cohort study // BMJ. 2012. Vol. 345.
Article ID e7895.
Sennerby U., Melhus H., Gedeborg R. et al. Cardiovascular diseases and risk of hip
fracture // JAMA. 2009. Vol. 302, N. 15. P. 1666-1673.
Seo G., Kim T., Chung J. Antithyroid drugs and congenital malformations: a nationwide Korean cohort
study // Ann. Intern. Med. 2018. Vol. 168, N. 6. P. 405-413.
Serretti A., Mandelli L. Antidepressants and body weight: a comprehensive review and meta-analysis //
J. Clin. Psychiatry. 2010. Vol. 71, N. 10. P. 1259-1272.
Sethi S., Sethi N., Wadhwa V. et al. A meta-analysis on the role of rectal diclofenac and indomethacin in
the prevention of post-endoscopic retrograde cholangiopancreatography pancreatitis // Pancreas.
2014. Vol. 43, N. 2. P. 190-197.
Shah N.H., LePendu P., Bauer-Mehren A. et al. Proton pump inhibitor usage and the risk of myocardial
infarction in the general population // PLoS One. 2015. Vol. 10,
N. 6. Article ID e0124653.
Shah N.H., Schneider T.R., DeFaria Yeh D. et al. Eosinophilia-Associated Coronary Artery Vasospasm in
Patients with Aspirin-Exacerbated Respiratory Disease // J. Allergy Clin. Immunol. Pract. 2016. Vol. 4, N.
6. P. 1215-1219.
Shaheen A.A., AlMattooq M., Yazdanfar S. et al. Tenofovir disoproxil fumarate significantly decreases
serum lipoprotein levels compared with entecavir nucleos(t)ide analogue therapy in chronic hepatitis B
carriers // Aliment. Pharmacol. Ther. 2017.
Vol. 46. P. 599-604.
Sharma A., Chatterjee S., Arbab-Zadeh A. et al. Risk of serious atrial fibrillation and stroke with use of
bisphosphonates: evidence from a meta-analysis // Chest. 2013.
Vol. 144. P. 1311-1322.
Sharma A., Einstein A.J., Vallakati A. et al. Risk of atrial fibrillation with use of oral and intravenous
bisphosphonates // Am. J. Cardiol. 2014. Vol. 113. P. 1815-1821.
Sharma A., Lavie C.J., Borer J.S. et al. Meta-analysis of the relation of body mass index to all-cause and
cardiovascular mortality and hospitalization in patients with
chronic heart failure // Am. J. Cardiol. 2015. Vol. 115. P. 1428-1434.
Источник KingMed.info
380
Sheng X., Murphy M.J., Macdonald T.M., Wei L. Effectiveness of statins on total cholesterol and
cardiovascular disease and all-cause mortality in osteoarthritis and rheumatoid arthritis // J. Rheumatol.
2012. Vol. 39, N. 1. P. 32-40.
Shi K.Q., Liu W.Y., Pan Z.Z. et al. Secondary prophylaxis of variceal bleeding for cirrhotic patients: a
multiple-treatments meta-analysis // Eur. J. Clin. Invest. 2013.
Vol. 43, N. 8. P. 844-854.
Shibata T., Kawakami S., Noguchi T. et al. Prevalence, clinical features, and prognosis of acute
myocardial infarction attributable to coronary artery embolism //
Circulation. 2015. Vol. 132. P. 241-250.
Shimada Y.J., Tsugawa Y., Brown D.M., Hasegawa K. Bariatric surgery and emergency department visits
and hospitalizations for heart failure exacerbation: population-
based, self-controlled series // J. Am. Coll. Cardiol. 2016. Vol. 67, N. 8. P. 895-903.
Shore S., Borgerding J.A., Gylys-Colwell I. et al. Association between hyperglycemia at admission during
hospitalization for acute myocardial infarction and subsequent
diabetes // Diabetes Care. 2014. Vol. 37, N. 2. P. 409-418.
Short P.M., Lipworth S.I.W., Elder D.H.J. et al. Effect of beta-blockers in treatment of chronic obstructive
pulmonary disease: a retrospective cohort study // BMJ. 2011. Vol. 342. Article ID d2549.
Sica D.A. Fibrate therapy and renal function // Curr. Atheroscler. Rep. 2009.
Vol. 11, N. 5. P. 338-342.
Simonian S.M., Lotfipour S., Wall C., Langdorf M.I. Challenging the superiority of amiodarone for rate
control in Wolff-Parkinson-White and atrial fibrillation //
Intern. Emerg. Med. 2010. Vol. 5. P. 421-426.
Simpson T., Saxon A., Stappenbeck C. et al. Double-blind randomized clinical trial of prazosin for
alcohol use disorder // AJP. 2018. Vol. 12. P. 1216-1224.
Sin D.D., Man S.F.P. Chronic obstructive pulmonary disease as a risk factor for cardiovascular morbidity
and mortality // Proc. Am. Thorac. Soc. 2005. Vol. 2. P. 8-11.
Sindet-Pedersen C., Lamberts M., Staerk L. et al. Combining oral anticoagulants with platelet inhibitors
in patients with atrial fibrillation and coronary disease // J. Am.
Coll. Cardiol. 2018. Vol. 15. P. 1790-1800.
Singh J.A., Yu S. Are allopurinol dose and duration of use nephroprotective in the elderly? A Medicare
claims study of allopurinol use and incident renal failure //
Ann. Rheum. Dis. 2017. Vol. 76, N. 1. P. 133-139.
Singh S., Loke Y.K., Enright P.L. et al. Mortality associated with tiotropium mist inhaler in patients with
chronic obstructive pulmonary disease: systematic review and meta-analysis of randomised controlled
trials // BMJ. 2011. Vol. 342. Article ID d3215.
Singh S., Loke Y.K., Spangler J.G. et al. Risk of serious adverse cardiovascular events associated with
varenicline: a systematic review and meta-analysis // CMAJ.
Соседние файлы в папке Библиотека им академика М.И. Перельмана